ecteinascidin 743 has been researched along with Biliary Tract Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aglietta, M; Bertotti, A; Capussotti, L; Cavalloni, G; Gammaitoni, L; Leone, F; MarchiĆ², S; Medico, E; Peraldo-Neia, C; Sassi, F; Soster, M; Trusolino, L | 1 |
1 other study(ies) available for ecteinascidin 743 and Biliary Tract Cancer
Article | Year |
---|---|
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Biliary Tract Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dioxoles; DNA Repair; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Histones; Humans; Interleukin-6; Mice; Mice, Inbred NOD; Neovascularization, Pathologic; Phosphorylation; Tetrahydroisoquinolines; Trabectedin; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2014 |